Logo

Interactive Biosoftware

Sophia Genetics Acquires Interactive Biosoftware
Premium

With its purchase of decision support technology maker Interactive Biosoftware, Sophia looks to extend its AI platform deeper into NGS interpretation.

Centogene Signs Collaboration Agreement With Interactive Biosoftware

The two companies plan to join their respective technologies in order to help clinicians better interpret genetic variant data.

Interactive Biosoftware, Genohm Ink Software Integration Agreement

The combined products will provide customers with a comprehensive solution for managing next-generation sequencing workflows in the lab.

Ranomics Touts Functional Genomics Studies as Solution to Genetic Testing Market's VUS Challenge
Premium

Ranomics is building a business around providing functional data on variants of unknown significance, starting with BRCA1 mutations.

Downloads and Upgrades: Alamut-HT 1.1, Ingenuity Systems
Premium

This week, Interactive Biosoftware released Alamut-HT 1.1, an upgraded version of its genomic variant annotation and interpretation software.
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.